Drugs / Inactivated and fragmented influenza vaccine
Inactivated and fragmented influenza vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03540823 | Apr → Jun 2018 | Sjogren syndrome, systemic lupus erythematosus | University of Sao Paulo General Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Inactivated and fragmented influenza vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03540823 ↗ |
| Modality | Vaccine | “inactivated and fragmented influenza vaccine” NCT03540823 ↗ |